James Leung, Ph.D is a Senior Research Fellow at the MIT Center for Biomedical Innovation (CBI). He serves as the lead investigator for the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) and the Biomanufacturing Consortium (BioMAN). He contributes to the design and implementation of biotechnology-related courses and serves as a lecturer in some of these courses at MIT. He maintains a strong connection to industrial practices by serving as a consultant/advisor to pharmaceutical and biotechnology companies and other research organizations. Before his current roles, Jim held full-time positions at Genentech, Repligen and Ipsen in the areas of process development, manufacturing and product development of recombinant biotherapeutics. Jim received a B.Sc. degree from the Chemical Engineering Department at MIT. For graduate studies, he completed a M.Sc degree and a Ph.D degree in Biochemical Engineering from MIT.